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Abstract
Background: Due to recent leaps forward in DNA synthesis and sequencing technology, DNA manipulation has been
extended to the level of whole-genome synthesis. Bacteriophages occupy a special niche in the micro-organic ecosystem
and have potential as a tool for therapeutic agent. The purpose of this study was to carry out chemical synthesis of the
bacteriophage G4 and the study of its infectivity.
Methodology/Principal Findings: Full-sized genomes of bacteriophage G4 molecules were completed from short
overlapping synthetic oligonucleotides by direct assembly polymerase chain reaction and ligase chain reaction followed by
fusion polymerase chain reaction with flanking primers. Three novel restriction endonuclease sites were introduced to
distinguish the synthetic G4 from the wild type. G4 particles were recovered after electroporation into Escherichia coli and
were efficient enough to infect another strain. The phage was validated by electron microscope. Specific polymerase chain
reaction assay and restriction analyses of the plaques verified the accuracy of the chemical synthetic genomes.
Conclusions: Our results showed that the bacteriophage G4 obtained is synthetic rather than a wild type. Our study
demonstrated that a phage can be synthesized and manipulated genetically according to the sequences, and can be
efficient enough to infect the Escherichia coli, showing the potential use of synthetic biology in medical application.
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Introduction
Bacteriophages, being viruses that infect bacteria, have played
an important role in underpinning the development and
advancement of the biosciences since the dawn of molecular
biology. Bacteriophages, first discovered around 1915, occupy a
special place in viral biology. They are perhaps the best
understood viruses. Their genome being less than 10,000 bases
long is particularly amenable to genetic alterations at the level of
whole genome synthesis thanks to the recent advance made in
DNA synthesis and sequencing technology. We may now modify
genetic information to an extent not possible before. Due to the
advances in synthetic biology, it is now possible to obtain large
segments of synthetic DNA, assemble them into entire genomes of
infectious agents, and boot them to life. Cello J et al [1] achieved
the first chemical synthesis of a DNA (7,500 bp) corresponding to
the entire genome of poliovirus. The DNA of the poliovirus was
the largest DNA sequence ever synthesized in 2002. By
establishing conditions for assembly of the genome, Venter
improved upon the methodology and completed the infectious
genome of bacteriophage WX174 (5,386 bp) within 2 weeks [2].
Researchers further made a distinct improvement in the scale of
synthesis which was the 582,970 bp genome of Mycoplasma
genitalium [3]. Once again, Venter and his colleagues succeeded
in creating the first living organism with a completely synthetic
genome [4]. A few medical applications of chemical genome
synthesis also have been described [5,6]. The common goal of this
new strategy is to further our understanding of an organism’s
properties and to make use of this new information to prevent or
treat human disease.
Bacteriophage G4, first isolated in 1973 [7], is a genus of
Escherichia coli (E. coli) phages of the family Microviridae. G4 or
WX174-like, is an icosahedra particle with almost the same density
as bacteriophage WX174 which has been used in many landmark
experiments, and contains single-stranded circular DNA [8]. The
5,577 nucleotide long sequence of bacteriophage G4 DNA has
been determined, with an average of 66.9% nucleotide sequence
similarity compared to that of bacteriophage WX174 [9]. These,
along with the successful whole genome assembly of bacteriophage
WX174, can validate G4 as an attractive target for chemical
synthesis in medical use.
G4 can only multiply within E. coli and kill the cells by lysis. E.
coli are the most common etiologic agent clinically associated with
Urinary Tract Infection (UTI) which is the most frequently
diagnosed kidney and urologic disease [10,11]. However, there is
documentation of increases multidrug-resistant pathogens [12].
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potential uses in human medicine [13]. Chemical synthesis of
G4 genomes will provide a new perspective of medical application.
All these facts induced us to carry out the synthesis of the WX-
like phage and the study of its infectivity. We set out to generate a
synthetic G4 genome (syn-G4) by whole genome assembly. To tell
the difference from the wild type of the phage G4, we genetically
alter 3 restriction endonuclease sites during the synthesis of the
genome and subsequently generate a mutated G4 genome (m-G4).
Two of these infectious circlular genomes produced were
electropotated into DH5a and the plaques of syn-G4 and m-G4
were observed after incubation. Both of the phages were
confirmed and were able to infect E. coli strain BL21. Our report
demonstrates that an infectious phage can be synthesized and
manipulated genetically according to the sequence published, and
efficient enough to infect the E. coli, showing the potential use of
synthetic biology for medical application.
Results
Chemical synthesis of syn-G4 and m-G4 genomes
The oligonucleotides were designed to synthesize a G4 genome
with exactly the same sequence reported by Godson et al. in 1978
[9] [NCBI Reference Sequence: NC_001420.2]. The sequence was
designed to make a molecule that could be cleaved to size with PstI
and then circularized to produce a circular molecule (Fig. 1).Three
restriction endonuclease sites (NcoI, KpnI and EcoRI, respectively)
were introduced to generate a m-G4 genome. Since the mutation
sites are located at the third base of the corresponding codon,
minimal structural and functional impact was expected. The
oligonculeotides were pooled and gel-purified by Sangon Biotech
as described in Materials and methods. The sequences of the short
custom-made segments were consistent with the results from both
sequencing and agarose gel. Full-sized genomes of syn-G4 and m-
G4 molecules were completed and provided by Shanghai Sangon
Biotech. Co., Ltd (data shown in Material S1).
Circularization of full-length genome and infectivity
testing
The polymerase chain reaction (PCR) productions of full-length
genomes were cleaved with PstI and then circularized by ligation
with T4 ligase using recommended conditions to generate
products of syn-G4 and m-G4 circular molecules, then each
10 ml of ligation product was electroporated into DH5a cells,
immediately diluted with 600 ml of liquid Luria-Bertani (LB)
medium, and then divided into two screwcapped glass culture
tubes. The tubes were rotated at 37uC for 60 min and then 200 ml
of culture fluid was stained to LB solid culture medium to stay
overnight at 37uC. Phage plaques were visualized after 6–12 h of
incubation at 37uC (Fig. 2, A, syn-G4; B, m-G4). The phage
formed small, clear, round plaques and some merged or ran
together to form a mass on the LB lawn. 10 ml of pure water
underwent the same procedures for control group. No plaque was
observed after incubation at 37uC (Fig. 2, C, control). Phage from
the plate underwent plaque purification and 100 ml of phage
suspension with an estimated concentration of 10
25/L was added
to 100 ml of log phase BL21. Phage plaques were visualized
incubation of 6–10 h but formed smaller plaques compared to
which generated by with a same concentration.
Morphology by electron microscope
Synthetic G4 samples were positive stained with 0.2% (w/v)
phosphotungstic acid and examined by transmission electron
microscopy, as seen in Fig. 3. The phage looked like an icosahedral
protein shell and the shape was seen approximately 50 nm in
diameter (Average of anteroposterior diameter and left-right
diameter).
Figure 1. Structure drawing of single-stranded circular syn-G4/m-G4 genome (5577 bp) and sites of restriction endonucleases. New
NcoI, KpnI and EcoRI sites marked in red slash were added into the m-G4 genome. Three specific PCR fragments were shown in yellow.
doi:10.1371/journal.pone.0027062.g001
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Three different parts of the genome were targeted for PCR
assay, considering each part coding important structural proteins.
The three specific PCR fragments, shown in yellow in Figure 1, of
both of syn-G4 and m-G4 were successfully amplified from
plaques purification using the specific primer pair (Tab. 1) and
confirmed with the results of sequencing. The resulting PCR
product was subjected to agarose gel electrophoresis (Fig. 4). The
645 bp PCR amplification products of both syn-G4 and m-G4
were validated by sequencing to ensure the sequences without
mutations and including the previous 3 restriction endonuclease
sites (data shown in File S1). The 645 bp sequence of syn-G4
contained only 1 KpnI site. These sequences of m-G4 contained 2
KpnI sites, 1 NcoI site and 1 EcoRI site after genetic alteration shown
in red in Figure 1 with slash at the position of 3016, 3328 and 3358
respectively. The 645 bp DNA products were subjected to
restriction enzyme digestion with EcoRI, KpnI and NcoI to excise
different segments according to the supplier’s recommendations.
Subsequently, m-G4 could be digested by EcoRI, KpnI and NcoI
respectively, but syn-G4 just could be digested by KpnI (Fig. 5).
Consistent with the sequencing results, the genetic alteration sites
were confirmed by restriction enzyme digestion.
In this report, the natural DNA was unavailable to the
experimenter. A chemical synthesis of a circular G4 genome was
transfected into E. coli, which produced viable bacteriophages and
caused E. coli lysis. To distinguish from the wild type G4, m-G4
was genetically modified with 3 restriction endonuclease sites,
which subsequently turned out to be an infectious phage after
transfection into E. coli. Both of the plaques could not be identified
in morphology, but there were obvious differences observed after
digestion of genomes with 3 restriction endonucleases. These
results demonstrate that the phages causing lysis of E. coli. were
originally from our designed syn-G4 and m-G4 ones. The
difference between G4 and M-G4 showed that this isolate is
synthetic rather than a wild type. The chemical synthesis of
genome was efficient enough to form infectious molecules and
subsequently infect the E. coli.
Discussion
The result in this report proves the correctness of Godson’s
sequence meaning that is accurate enough to produce an
infectious phage. The genetic modification of syn-G4 subsequently
generating m-G4 validates the capability of manual manipulation.
The development of synthetic approach is still at an early stage,
but this field of research has attracted much attention [14,15]. The
methodology of synthetic biology has been improved, from
forming an infectious agent to a cellular genome with high
efficiency and yield. Apart from the resurrection of the 1918
influenza virus and the generation of codon- and codon pair-
deoptimized polioviruses, researchers have reengineered bacterio-
phages to combat antibiotic-resistant bacteria by endowing them
with genetic mechanisms that destroy bacterial mechanisms for
evading antibiotic action [16,17]. Therefore, phage therapy,
especially using synthetic phages, might be an alternative method
to control and combat pathogenic bacteria in human medicine.
From a practical perspective, UTI mainly caused by uropatho-
genic E. coli (UPEC) is easy to recur. For such a stubborn UTI
infection, a phage designed to destroy UPEC is one potential
treatment. We propose to assemble larger genomes required for an
entire phage that can be programmed to target specific pathogenic
agents and pathological mechanisms, without significant impair-
ment of the phage’s ability to replicate. Chemical synthesis of G4 is
the first attempt but there are still many challenges. Meanwhile, a
lot of work still needs to be done to test the relevant theories and
principles. However, the oligonucleotide synthesis combined with
the modifications of a phage genome described here will serve as a
basis for understanding the procedure. Given the synthetic
approaches available and the present knowledge of phage biology,
this new strategy may have potential use in antimicrobial
therapies. Whole G4 genome assembly will further enhance the
role of a synthetic approach for medical application. This new field
of research needs to be explored thoroughly in order to meet the
present and future medical demands.
Materials and Methods
Chemical synthesis of genomes
The oligonucleotides were designed to generate a syn-G4
genome according to the sequence reported by Godson [9].
According to the reference sequence, we mutated T-A, T-G and
T-C at the position of 3016 bp 3244 bp and 3328 bp respectively
to produce three novel restriction endonuclease sties (NcoI, KpnI
and EcoRI, respectively) in order to distinguish from the wild type
G4 genome. The full-sized genomes of bacteriophage G4 and m-
G4 were synthesized and provided by Sangon Biotech Co., Ltd
(Shanghai). Basically, for synthesis of the full-sized genomic DNA,
each of syn-G4 and m-G4 genomes was divided into 4 segments,
including A,B1,B2,and B3(syn-G4: 5996A: 925 bp,
5996B1:1410 bp, 5996B2: 1250 bp, 5996B3 2091 bp;m-G4:
5996A: 925 bp, 5997B1:1410 bp, 5996B2: 1250 bp, 5996B3
2091 bp). All oligonucleotides were chemically synthesized by
Sangon Biotech. The resultant fragments of various lengths with
overlap were added together and finally assembled into full-sized
genome by direct assembly PCR and ligase chain reaction (LCR)
followed by fusion PCR with flanking primers from short
overlapping synthetic oligonucleotides. The linear full-sized
Figure 2. Close up images of the plaques (A, syn-G4; B, m-G4)
and the bacterial lawns without plaques (C, control). The
plaques appeared small, clear and round. Some merged or ran together
to form a mass. The appearance of the plaques of both syn-G4 and m-
G4 showed no difference in A and B (A, syn-G4; B, m-G4).
doi:10.1371/journal.pone.0027062.g002
Figure 3. Synthetic G4 morphology by transmission electron
microscope (Arrow). Magnification: 800,0006. Bar: 100 nm.
doi:10.1371/journal.pone.0027062.g003
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and the use of preexisted PstI restriction sites for preparation of
sticky ends using recommended conditions. Transfection of cells
with the circular synthetic genome resulted in appearance of
infective plaques.
Circularization of linear genome DNA molecules
PCR products of full-sized genomes were pooled and confirmed
by sequencing. The linear DNA products were cleaved with PstI
and then circularized by ligation with T4 ligase using recom-
mended conditions. The ligation mixture was stayed overnight at
22uC in preparation for infectivity testing.
Assay of G4 plaques
One microliter of syn-G4 ligation product was electroporated
into DH5a cells (Biononatech Co., Ltd, Shenzhen, China),
immediately diluted with 600 ml of liquid LB medium, and then
divided into two screwcapped glass culture tubes. The two tubes
were rotated at 37uC for 60 min and then 200 ml of culture fluid
was stained to LB medium A to stay overnight at 37uC. Another
microliter of m-G4 and pure water underwent the same
procedure and each of 200 ml of culture fluid was stained to LB
medium B and C respectively, to stay overnight at 37uC. Phage
plaques in A and B were visualized after 6–12 h of incubation at
37uC and recorded by photography at 8 h. No plaque was
observed in C.
Electron microscopy
Several plaques were picked up to 1.5 ml Eppendorf and 0.5 ml
of 2.0% (w/v) glutaraldehyde was added for fixation before
examination. A concentrated phage sample was negatively stained
with 0.2% (w/v) phosphotungstic acid on a carbon-coated grid
and examined by JEM100CXII (Japan) transmission electron
microscope (Electron Microscope Laboratory, School of Life
Sciences, Sun Yat sen University, Guangzhou) at an accelerating
voltage of 80 kV. Electron micrographs were taken at a
magnification of 800,0006. The phage size was determined from
the average of two independent measurements (Anteroposterior
diameter and left-right diameter).
Plaques purification and assay of infectivity
A confluent plaque was picked up and covered with 50 mlS M
buffer (50 ml 1 M tris-cl(PH 7.5), 2 g MgSO4, 5.8 g NaCl, 5 ml
2% gelatin and ddH2O up to 1 L), gently shaken and maintained
in the refrigerator at 4uC for 3 min. After adding a few drops of
chloroform, the plate is manually shaken. The phage suspension
Figure 4. PCR of specific sequences. Agarose gel showing the PCR results obtained when specific primers were used. Lane 1, D2000 marker; Lane
2, 3 and 4, PCR amplification of the three specific products 603 bp, 443 bp and 645 bp, respectively, of syn-G4 (Location shown in Fragment 3, 1 and
2 in yellow in Fig. 1, respectively); Lane 4, 5 and 6, PCR amplification of the three specific products 603 bp, 443 bp and 645 bp, respectively, of m-G4
(Location shown in Fragment 3, 1 and 2 in yellow in Fig. 1, respectively).
doi:10.1371/journal.pone.0027062.g004
Table 1. Primers for specific PCR.
Target Sequences PCR Product (bp)
Syn-G4 59-CAAAAATCTTGGAGGAGTCAACTATGAAGTCTC-39 443
59-GGAGTACCGGACTGCGATGGGCATAGAGTAAC-39
Syn-G4 59-GCCTACGGAGATACTCGAGTCTCCGATAC-39 603
59-GGTTGAAGGACGGTTGCTTCACGGTTTAC-39
Syn-G4 59-TCTATATCCCACACCGTCATATCTACGGTC-39 645
59-TAATTACGCGATGCTCAGGAACATAGAAG-39
m-G4 59-CAAAAATCTTGGAGGAGTCAACTATGAAGTCTC-39 443
59-GGAGTACCGGACTGCGATGGGCATAGAGTAAC-39
m-G4 59-GCCTACGGAGATACTCGAGTCTCCGATAC-39 603
59-GGTTGAAGGACGGTTGCTTCACGGTTTAC-39
m-G4 59-TCTATATCCCACACCGTCATATCTACGGTC-39 645
59-TAATTACGCGATGCTCAGGAACATAGAAG-39
doi:10.1371/journal.pone.0027062.t001
Synthetic Bacteriophage G4
PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e27062was centrifuged (50006g for 10 min) to remove DH5a and
debris. The 200 ml of the supernatant was retrieved and diluted
to the proper concentration (10
27/L,10
25/L) for infectivity
test. E. coli strain BL21 (Biononatech Co., Ltd, Shenzhen,
China) colony was picked up to 5 ml LB culture medium to
prepare log phase of BL21. BL21 were grown in LB broth
without antibiotic selection at 37uC until an OD600 of 0.4 was
reached. Bacterial cells were diluted in LB broth to a final
density of 10
6 CFU/ml. An aliquot of cells (10
5 CFU, 100 ml)
was added with 100 ml phage suspension with a diluted
concentration of 10
25/L and mixed with 0.7% soft agar, slightly
shaken, then the mixture was plated on LB plates, following
overnight incubation at 37uC. Phage plaques were visualized
after 6,1 8ho fi n c u b a t i o na t3 7 uC.
PCR assay and DNA sequencing
Specific primers for syn-G4 and m-G4 were synthesized by
Jierui Biotech co., Ltd. (Guangzhou), and their sequences were
listed in Table 1. The expected length of the amplification product
was 443 bp, 603 bp and 645 bp respectively. Plaques purified
were picked directly into 50 ml PCRs respectively. Each reaction
mixture contained 2.5 of phage suspension, 1.5 ml of 25 mmol/L
MgCl2,2ml of 2.5 mmol/L dNTP, 1.0 ml of each 20 pmol/L
primer, 0.4 ml of 5 U/L Taq polymerase (Takara), 25 of
primerstar, and ddH2O up to total 50 ml. PCR of NLE-pCMV10
for NLE gene was also performed as the control group (date not
shown). w The conditions for PCR were as follows: 99uC for
2 min, followed by 30 cycles of 98uC, 10 s, 68uC, 40 s, 72uC,
10 min and a final extension of 72uC for 7 min. The PCR was
performed as previously described. The PCR products were
analyzed using a Rapid Agarose Gel Electrophoresis System
(Wealtec Corp, Sparks, Nev) in 1.0% agarose gels in 5.0 ml loading
buffer (10 min at 90 V). The genome was gel-purified and
sequenced on a 3730 XL sequencer (3730 XL sequencer, ABI,
Sangon) with depth of 2-fold. Sequencing of the cloned
amplification product confirmed that it was identical to part of
the syn-G4 and m-G4.
Restriction analyses
For restriction analyses, 10 ml of PCR products with expected
length of 645 bp were digested with restriction endonucleases
(EcoRI, KpnI and NcoI) according to the supplier’s recommenda-
tions (Takara, Dalian, China). Digestion of syn-G4 and m-G4 with
2.0 mlo fEcoRI restriction endonuclease (Takara, Dalian) was done
at 37uC in 10 m M Tris-HCl, 50 mM NaCl, 15 mM MgCl2,
pH 7.5. DNA was digested with 2.0 mlo fKpnI endonuclease
(Takara, Dalian) at 37uC in 10 mM Tris-HCl, 10 mM MgCl2,
0.02% Triton X-100, 0.1 mg/ml BSA. Digestion of DNA with
2.0 mlo fNcoI restriction endonuclease (Takara, Dalian) was done
at 37uC 10 mM Tris-HCl, 50 mM KCl, 1 mM DTT, 0.1 mM
EDTA, 0.2 mg/ml BSA and 50% glycerol. The digested DNA
was examined by gel electrophoresis after 10 hours digestion. The
resultant fragments were separated and purified as described
above.
Gel electrophoresis
DNA was analyzed using a 6.0% (w/v) agarose gel in TAE
buffer (40 mmol l
21 Tris acetate; 2 mmol L
21 EDTA, pH 8.3)
with 0.5 mmg ml
21 ethidium bromide. Electrophoresis was
performed at constant voltage 90 V) for 30 min and visualized
by UV light (300 nm) after staining with ethidium bromide (1 Ag/
ml). This procedure was followed for all the experiments except
where stated differently. The relative sizes of the DNA fragments
were estimated by comparing their electrophoretic mobility with
that of the standards run with the samples on each gel
(D2000marker).
Figure 5. Digestion of restriction endonuclease. Lane 1, D2000marker. Agarose gels (Lane 2, 4, 6) showing the products (shown in Fragment 2
in Fig. 1) of syn-G4 digested by restriction endonucleases and generations of restriction endonuclease digestion fragments of 645 bp (EcoRI),
125 bp+520 bp (KpnI) and 645 bp (NcoI), respectively. The 3 modified restriction endonuclease sites of m-G4 were confirmed by agarose gels and
different digestion fragments of 518 bp+127 bp (EcoRI), 125 bp+423 bp+97 bp (KpnI), and 209 bp+436 bp (NcoI) (Lane 3, 5 and 7 respectively), were
observed.
doi:10.1371/journal.pone.0027062.g005
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In order to accomplish the synthesis of infectious G4 genome,
we had considered the replication mechanism of G4 [18] and
analyzed the methodology of chemical synthesis of genome [19–
21]. When the sequence of phage G4 was determined by Godson,
its structure was almost understood. During the stage of phage G4
replication, there was a circular double-stranded DNA called
replication form (RF form) [22]. It was not yet possible for us to
synthesize entire genome as long continuous strands of DNA. In
designing the oligonclotiedes sets, we adopted the basic methods
available for assembling long DNA sequences and the strategy of
dividing the genome into 4 segments. Each segment was also
divided into 2 or 3 shorter pieces (data not shown). These entire
short custom-made single-stranded DNA with overlap were
assembled from the oligonucleotides. These segments were finally
assembled into full-sized genome by direct assembly PCR and
ligase chain reaction (LCR) [21]. These synthetic phage G4 was
referred to the G series of X-like phages. They were subsequently
grown and handled by all of the methods commonly used for
WX174 [7]. The linear G4 molecules were then circularized to
form a circular RF form after gel-purified using recommended
conditions [2].
Supporting Information
Material S1 Full-sized genomes of syn-G4 and m-G4
molecules.
(DOC)
File S1 Trace files for specific PCR fragments, syn-G4
genome and m-G4 genome.
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